Condition
Anogenital Human Papilloma Virus Infection
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06809777Phase 2Not Yet RecruitingPrimary
Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts
NCT02576054Phase 3CompletedPrimary
Safety and Tolerability Study of V501 in Japanese Boys (V501-200)
NCT01862874Phase 3CompletedPrimary
Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)
NCT01427777UnknownPrimary
3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China
Showing all 4 trials